Article

Humana Reduces 2012 Forecast as Medicare Costs Increase

Humana Inc. (HUM)

, the second-biggest provider of Medicare benefits, fell the most in more than three years after cutting its 2012 profit forecast on higher-than- anticipated costs.

Humana tumbled 9.8 percent to $63.66 at 10:17 a.m. in New York trading, after dropping as much as 10 percent for its biggest intraday decline since March 2009. Earnings this year may be $6.90 to $7.10 a share, the Louisville, Kentucky-based health plan said yesterday in a statement. That was below the $7.88 average of 10 analyst estimates compiled by Bloomberg.

Read the full story: http://tinyurl.com/c7rqfk6

Source: Bloomberg

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Dr Johnie Rose
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Leigh Maria Ramos-Platt, MD
Molly Dean, MSW, Siftwell
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo